On the contrary, the soluble isoform of TNFRSF9 that we measured, generated by alternative splicing48, has been shown to antagonize antitumor immune response hence promote tumor survival most likely by acting as decoy receptor49,50. This evidence concerns the gene TNFRSF9 and neoplasm.